-
-
-
-
-
-
-
ANI Pharmaceuticals projects 2026 revenue to exceed $1 billion
-
-
-
-
-
-
-
ANI Pharmaceuticals (ANIP) PT Raised to $93 at H.C. Wainwright
-
-
-
-
-
-
-
ANI Pharmaceuticals (ANIP) PT Raised to $65 at Truist on 'Improved Outlook'
-
-
-
-
-
-
-
ANI Pharma (ANIP) Announces FDA Approval of New Purified Cortrophin Gel Prefilled Syringe
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on ANI Pharmaceuticals (ANIP)
-
-
-
-
-
-
-
ANI Pharma (ANIP) Launches Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution
-
-
-
-
-
-
-
ANI Pharma (ANIP) Announces FDA Approval and Launch of Naproxen Delayed-Release Tablets
-
413,532 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

